Results 101 to 110 of about 1,719 (152)

Point-Of-Care Drug-Checking: Assessing the Rhode Island Drug Supply Using FTIR Spectroscopy to Detect Fentanyl, Xylazine and Other Substances. [PDF]

Drug Alcohol Rev
Ujeneza M, Tardif J, Thompson E, Badea A, Morales A, Altomare-Jarczyk C, Green TC, Serafinski R, McKenzie M, Park JN.   +9 more
europepmc   +1 more source

Barriers and facilitators to initiating and adhering to harm reduction services among people who inject drugs in the United States: a systematic review. [PDF]

Harm Reduct J
Nacht CL, Skaathun B, Ogarrio K, Durbin-Matrone R, Wright L, Reich R, Reich K, Stojanovski K.   +7 more
europepmc   +1 more source

The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV. [PDF]

Addict Sci Clin Pract
Appa A, Marti XL, Baral S, Shoptaw S, Bazazi AR, Spinelli MA, Glidden D, Gandhi M, Coffin P.   +8 more
europepmc   +1 more source

Predictors of Awareness of Fentanyl Test Strips Among People Who Inject Drugs in Northeast Georgia

Substance Use & Misuse
Mohammad Rifat Haider, Husna B. Merchant, Samantha Clinton, Sayward E. Harrison, Nathan B. Hansen, Jayani Jayawardhana   +5 more
openaire   +2 more sources

'Tranq': perceptions of xylazine and harm reduction practices among people receiving treatment for substance use disorders. [PDF]

Harm Reduct J
Salwan A, Dowling-McClay K, Greer D, AlAli A, Brooks B.   +4 more
europepmc   +1 more source

U.S. substance use harm reduction efforts: a review of the current state of policy, policy barriers, and recommendations. [PDF]

Harm Reduct J
Pridgen BE, Bontemps AP, Lloyd AR, Wagner WP, Kay ES, Eaton EF, Cropsey KL.   +6 more
europepmc   +1 more source

Implementation of Harm Reduction Syringe Services Programs at 2 Veterans Affairs Medical Centers. [PDF]

Fed Pract
Burkett M, Litke J, Percy A, Plank K, Richardson K, Kirkland M.   +5 more
europepmc   +1 more source

Nitazenes: The Emergence of a Potent Synthetic Opioid Threat. [PDF]

Molecules
Pereira JRP, Quintas A, Neng NR.
europepmc   +1 more source

Harm reduction approaches for the use of benzodiazepines: a scoping review. [PDF]

Harm Reduct J
Morrison C, Natale I, Branchflower A, Harvey C, Lundin RM.   +4 more
europepmc   +1 more source

"Because we're the experts": centering the expertise of people who use drugs to identify and propose solutions for overdose prevention. [PDF]

Harm Reduct J
Bailey EJ, Becker M, Morrow J, Schaefer R, Angeles S, Kemp P, Crews Z, Mijal K, Striebel J, Conway CJ, Claypool E, Seal DW, Salisbury-Afshar EM, Westergaard RP, Gicquelais RE.   +14 more
europepmc   +1 more source